ScreenerHero

JUSHJushi Holdings Inc.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · jushico.com
0.8300CAD+23.88%Mkt Cap: 120.71M $P/E: —

Jushi Holdings Inc. engages in the retail, distribution, cultivation, and processing of cannabis for medical and adult-use markets in the United States. The company offers flower, vapes, concentrates, infused chews and c…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$62.66BUSDP/E 24.3
TAK
Takeda Pharmaceutical Company Limited
$60.33BUSD
TEVA
Teva Pharmaceutical Industries Limited
$46.72BUSDP/E 66.8
HLN
Haleon plc
$41.16BUSDP/E 19.5
ZTS
Zoetis Inc.
$29.48BUSDP/E 11.6
ZOE
Zoetis Inc.
$27.77BUSDP/E 11.6
UTHR
United Therapeutics Corporation
$21.22BUSDP/E 17.7
VTRS
Viatris, Inc.
$19.47BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.80BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.63BUSDP/E 21.0
IPN
Ipsen S.A.
$13.27BUSDP/E 24.0
ELAN
Elanco Animal Health Incorporated
$11.20BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.33BUSDP/E 30.2
KRK
Krka, d. d.
$8.66BUSDP/E 18.8
ALKS
Alkermes plc
$7.41BUSDP/E 116.3
AMRX
Amneal Pharmaceuticals, Inc.
$7.02BUSDP/E 42.0
HIMS
Hims & Hers Health, Inc.
$6.85BUSD
LNTH
Lantheus Holdings, Inc.
$6.55BUSDP/E 24.0
KNSA
Kiniksa Pharmaceuticals International, plc
$6.10BUSDP/E 78.9
LQDA
Liquidia Corporation
$5.95BUSDP/E 47.5

Key Statistics

Company
Market Cap120.71M $
Enterprise Value320.81M $
Revenue (TTM)197.90M $
Gross Profit83.00M $
Net Income (TTM)-49.95M $
Revenue/Share1.006 USD
Last Price0.8300 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1.3K
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-7.77
PEG—
EV/EBITDA10.42
EV/Revenue1.62
P/S0.64
P/B-0.88
EPS (TTM)-0.50
EPS (Forward)-0.11
52W Range
0.490040% of range1.330
52W High1.330 CAD
52W Low0.4900 CAD
Profitability
Gross Margin43.35%
Oper. Margin3.11%
EBITDA Margin15.55%
Profit Margin-26.09%
ROE59.47%
ROA-16.24%
Growth
Revenue Growth9.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF12.91M $
CapEx (TTM)12.59M $
FCF Margin-0.98%
FCF Yield-1.60%
Net Debt194.29M $
Net Debt/EBITDA6.31
Balance Sheet
Debt/Equity-2.54
Current Ratio0.83
Quick Ratio0.41
Book Value/Sh-0.9887 CAD
Cash/Share0.1670 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateApr 27, 2018
Analyst Consensus
Rating—
Target (Mean)1.975 CAD
Upside (mean)+138.0%
Target Range1.700 CAD – 2.250 CAD
CAD1.700+138.0% to meanCAD2.250
# Analysts2
Ownership
Shares Out.199.70M
Float180.09M
Insiders16.33%
Institutions12.11%
Short Interest
Short Ratio0.1d
Short % Float0.00%
Short % Out.0.00%
Shares Short5.15K
Short (prev mo.)11.71K
Technical
SMA 500.6768 (+22.6%)
SMA 2000.7095 (+17.0%)
Beta0.94
S&P 52W Chg14.29%
Avg Vol (30d)51.41K
Avg Vol (10d)44.55K
Technical Indicators
RSI (14)57.6
MACD0.0060
MACD Signal-0.0049
MACD Hist.+0.0109
BB Upper0.6834 CAD
BB Middle0.6000 CAD
BB Lower0.5166 CAD
BB Width27.78%
ATR (14)0.0448 CAD
Vol Ratio (20d)2.90x